Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 3 2Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 27Dexmedetomidine 8Radiotherapy 7Radiation 7Proton Therapy 7Mental Status and Dementia Tests 7Magnetic Resonance Imaging 7Exercise 6Surgical Procedures, Operative 5Specimen Handling 5Saline Solution 5Blood Specimen Collection 5Bevacizumab 5Remifentanil 4Radiotherapy, Intensity-Modulated 4Propofol 4alovudine 3Transcranial Magnetic Stimulation 3Temozolomide 3Resistance Training 3Methods 3Mannitol 3Diffusion Tensor Imaging 3Cognitive Training 3gadobutrol 2gadobenic acid 2Yoga 2Vitamin D 2Ultrasonography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brain Neoplasms × Levetiracetam × Clear all
NCT00415376 2012-05-18

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Northwestern University

Phase NA Withdrawn
CNS

Brain Neoplasms, Seizures, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡